• Product NamePomalidomide
• Brief DescriptionInhibitors
• Purification99.50%
• Biological ActivityPomalidomide inhibits LPS-induced TNF-α release with IC50 of 13 nM in PBMCs.
• Target NameTNF inhibitor
• CAS No. 19171-19-8
• Calculated MW 273.24
• Formulation C13H11N3O4
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Cancer
  SMILES:NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O
  Pathways:Apoptosis
  Receptor:TNF-α
  Boling pt:
  Melting pt:
  Solubility:DMSO: 55 mg/mL (201.28 mM)
  Appearance:Yellow Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Muller GW, et al. Bioorg Med Chem Lett, 1999, 9(11), 1625-1630.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting